Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Allosteros Therapeutics in January, 2016 for $249,025.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL131089-01 | Phase I | 249,025 | January 11, 2016 | |||||||
A SBIR Phase I contract was awarded to Allosteros Therapeutics in September, 2017 for $243,415.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK116345-01 | Phase I | 243,415 | September 18, 2017 | |||||||
A SBIR Phase I contract was awarded to Allosteros Therapeutics for $257,362.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL115883-01 | Phase I | 257,362 | ||||||||
A SBIR Phase I contract was awarded to Allosteros Therapeutics for $249,701.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS077639-01 | Phase I | 249,701 | ||||||||
A SBIR Phase I contract was awarded to Allosteros Therapeutics for $212,916.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL108404-01 | Phase I | 212,916 | ||||||||
A SBIR Phase I contract was awarded to Allosteros Therapeutics for $279,182.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA159562-01A1 | Phase I | 279,182 | ||||||||
A SBIR Phase I contract was awarded to Allosteros Therapeutics for $249,171.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL110614-01 | Phase I | 249,171 |